bromodeoxyuridine has been researched along with fk 409 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, Y; Motoyama, Y; Nishio, M; Seki, J; Yoshida, K | 1 |
| Abe, T; Aitouche, A; Fukada, J; Kurimoto, Y; Pang, M; Pham, SM; Ruiz, P; Schena, S; Striker, LJ; Tack, I | 1 |
2 other study(ies) available for bromodeoxyuridine and fk 409
| Article | Year |
|---|---|
FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty.
Topics: Angioplasty, Balloon; Animals; Bromodeoxyuridine; Carotid Arteries; Carotid Artery Injuries; Cell Division; Cells, Cultured; Cyclic GMP; Disease Models, Animal; Isosorbide Dinitrate; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitro Compounds; Rats; Rats, Sprague-Dawley; Tunica Intima; Vasodilator Agents | 1995 |
FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model.
Topics: Animals; Aorta; Apoptosis; Bromodeoxyuridine; Cyclosporine; Immunohistochemistry; Male; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitro Compounds; Rats; Rats, Inbred ACI; Rats, Inbred WF; Transplantation, Homologous | 2000 |